# A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

> **NCT00402714** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 14 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **PROCEDURE:** extracorporeal photopheresis
- **DRUG:** Pentostatin
- **RADIATION:** Total Body Irradiation
- **DRUG:** Pentostatin
- **RADIATION:** Total Body Irradiation

## Key facts

- **NCT ID:** NCT00402714
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402714, "A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00402714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*